ACURX PHARMACEUTICALS INC (ACXP)

US00510M1045 - Common Stock

2.17  +0.05 (+2.36%)

After market: 2.2 +0.03 (+1.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-14.58M-12.09M-12.75M-4.60M-5.93M
Change In Working Capital
1.01M1.25M140.00K-800.00K1.05M
Other non cash items
3.77M3.30M7.59M2.05M900.00K
OPERATING CASH FLOW
-9.80M-7.54M-5.01M-3.35M-3.99M
 
CASH FLOWS FROM INVESTING ACTIVITIES
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
N/AN/A0.0070.00K0.00
Stock Issued/Repurchased
8.16M3.70M14.80M3.98M4.00M
Other Financing Activity
N/AN/AN/A0.00450.00K
FINANCING CASH FLOW
8.16M3.70M14.80M4.04M4.46M
 
CHANGE IN CASH
-1.64M-3.85M9.78M690.00K470.00K
 
FREE CASH FLOW
Operating Cash Flow
-9.80M-7.54M-5.01M-3.35M-3.99M
FREE CASH FLOW
-9.80M-7.54M-5.01M-3.35M-3.99M

All data in USD

Charts